These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33493106)

  • 21. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).
    Kindgen-Milles D; Brandenburger T; Braun JFW; Cleff C; Moussazadeh K; Mrosewski I; Timm J; Wetzchewald D
    PLoS One; 2021; 16(4):e0248813. PubMed ID: 33831032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study.
    Kahlert CR; Persi R; Güsewell S; Egger T; Leal-Neto OB; Sumer J; Flury D; Brucher A; Lemmenmeier E; Möller JC; Rieder P; Stocker R; Vuichard-Gysin D; Wiggli B; Albrich WC; Babouee Flury B; Besold U; Fehr J; Kuster SP; McGeer A; Risch L; Schlegel M; Friedl A; Vernazza P; Kohler P
    Clin Microbiol Infect; 2021 Sep; 27(9):1336-1344. PubMed ID: 34020033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe.
    Rusakaniko S; Sibanda EN; Mduluza T; Tagwireyi P; Dhlamini Z; Ndhlovu CE; Chandiwana P; Chiwambutsa S; Lim RM; Scott F; Sibanda LM; Mutapi F
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009254. PubMed ID: 33788840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.
    Chen Y; Tong X; Wang J; Huang W; Yin S; Huang R; Yang H; Chen Y; Huang A; Liu Y; Chen Y; Yuan L; Yan X; Shen H; Wu C
    J Infect; 2020 Sep; 81(3):420-426. PubMed ID: 32504745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical Leave Associated With COVID-19 Among Emergency Medical System Responders and Firefighters in New York City.
    Prezant DJ; Zeig-Owens R; Schwartz T; Liu Y; Hurwitz K; Beecher S; Weiden MD
    JAMA Netw Open; 2020 Jul; 3(7):e2016094. PubMed ID: 32706380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
    Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Seroprevalence Among First Responders in Northeastern Ohio, 2020.
    Zhang X; Saade E; Noguez JH; Schmotzer C
    Public Health Rep; 2023; 138(1):140-148. PubMed ID: 36114657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.
    Biggs HM; Harris JB; Breakwell L; Dahlgren FS; Abedi GR; Szablewski CM; Drobeniuc J; Bustamante ND; Almendares O; Schnall AH; Gilani Z; Smith T; Gieraltowski L; Johnson JA; Bajema KL; McDavid K; Schafer IJ; Sullivan V; Punkova L; Tejada-Strop A; Amiling R; Mattison CP; Cortese MM; Ford SE; Paxton LA; Drenzek C; Tate JE;
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):965-970. PubMed ID: 32701941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
    Rogawski McQuade ET; Guertin KA; Becker L; Operario D; Gratz J; Guan D; Khan F; White J; McMurry TL; Shah B; Garofalo S; Southerland M; Bear K; Brush J; Allen C; Frayser A; Vokes R; Pershad R; Peake L; deFilippi C; Barackman K; Bearman G; Bidanset A; Farrell F; Trump D; Houpt ER
    JAMA Netw Open; 2021 Feb; 4(2):e2035234. PubMed ID: 33555331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 seroprevalence among firefighters in Los Angeles, California.
    Mulligan K; Berg AH; Eckstein M; Hori A; Rodriguez A; Sobhani K; Toubat O; Sood N
    Occup Environ Med; 2022 May; 79(5):315-318. PubMed ID: 35074885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders-The COVID-19 Arapahoe SErosurveillance Study (CASES) Project.
    Sabourin KR; Schultz J; Romero J; Lamb MM; Larremore D; Morrison TE; Frazer-Abel A; Zimmer S; Kedl RM; Jaenisch T; Rochford R
    J Occup Environ Med; 2021 Mar; 63(3):191-198. PubMed ID: 33298759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.
    Khoury R; Bernstein PS; Debolt C; Stone J; Sutton DM; Simpson LL; Limaye MA; Roman AS; Fazzari M; Penfield CA; Ferrara L; Lambert C; Nathan L; Wright R; Bianco A; Wagner B; Goffman D; Gyamfi-Bannerman C; Schweizer WE; Avila K; Khaksari B; Proehl M; Heitor F; Monro J; Keefe DL; D'Alton ME; Brodman M; Makhija SK; Dolan SM
    Obstet Gynecol; 2020 Aug; 136(2):273-282. PubMed ID: 32555034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
    Petersen MS; Strøm M; Christiansen DH; Fjallsbak JP; Eliasen EH; Johansen M; Veyhe AS; Kristiansen MF; Gaini S; Møller LF; Steig B; Weihe P
    Emerg Infect Dis; 2020 Nov; 26(11):2761-2763. PubMed ID: 32726200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022.
    Madinga J; Mbala-Kingebeni P; Nkuba-Ndaye A; Baketana-Kinzonzi L; Matungulu-Biyala E; Mutombo-Lupola P; Seghers CA; Smekens T; Ariën KK; Van Damme W; Kalk A; Peeters M; Ahuka-Mundeke S; Muyembe-Tamfum JJ; Vanlerberghe V
    J Health Popul Nutr; 2024 Jun; 43(1):74. PubMed ID: 38824595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of SARS-CoV-2 antibodies among North Dakota community pharmacy personnel: A seroprevalence survey.
    Johnson A; Vincent B; Carson P; Skoy E
    J Am Pharm Assoc (2003); 2021; 61(3):e127-e132. PubMed ID: 33568267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting COVID-19 Clusters at High Spatiotemporal Resolution, New York City, New York, USA, June-July 2020.
    Greene SK; Peterson ER; Balan D; Jones L; Culp GM; Fine AD; Kulldorff M
    Emerg Infect Dis; 2021 May; 27(5):1500-4. PubMed ID: 33900181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.